Research proposal Summary

An observational study of canine osteosarcoma in dogs receiving homeopathy as an adjunct to conventional treatment


This will be an observational study of 30 dogs suffering from canine osteosarcoma receiving homeopathic treatment as an adjunct to conventional treatment.  The survival times for dogs receiving homeopathy plus conventional treatment will be compared to established survival times of dogs receiving conventional treatment only Survival time means from diagnosis to euthanasia.

This study will set up systematic scrutiny of treatment outcomes of 30 dogs referred by veterinary surgeons with a confirmed diagnosis.    Whilst no causative link between treatment and outcomes can be drawn from an uncontrolled trial, observational studies can provide useful information about what is occurring in practice  However results will be interpreted with caution, as higher numbers of participants are needed to overcome random effects in estimating the direction and magnitude of treatment effects.

Objectives of the study

The objective is to systematically record the life span of dogs diagnosed with osteosarcoma receiving homeopathy as adjunctive care to conventional treatment regime and to compare these results with the most authoritative data available on conventional survival times, subject to variables such as site, stage and size of tumour, metastasises, age of dog, and chemotherapy agent/s. The results will be written up and submitted for publication to a peer review veterinary science publication

Principal investigator (PI)

Geoff Johnson MA Vet MB MRCVS. VetFFHom. RSHom. PCH

Address: Wiveliscombe Homeopathic Veterinary Surgery, 12 North Street, Wiveliscombe, Somerset TA42JY

01984 624999


Geoff Johnson qualified as a veterinary surgeon (vet) in 1987, and subsequently qualified in veterinary homeopathy 1999.  He is the principal of a busy homeopathic veterinary surgery   in West Somerset.  He lectures frequently at home and abroad.  He wrote the curriculum and taught the Danish Homeopathic Veterinary Diploma which has just graduated nine vets.  He is one of the few UK veterinary surgeons who treat animals diagnosed with cancer using homeopathy.  He lectured to conventional vets on this subject at the SW and London Vet Shows in 2014

Potential impact on homeopathic veterinary research

If the results obtained with five dogs previously treated solely with homeopathy by the PI, can be replicated, then it will be become clear that homeopathy could offer potential for extending life for dogs diagnosed with canine osteosarcoma.

The PI’s aspirations for research into homeopathic treatment of dogs diagnosed with osteosarcoma are:

  • To improve the quality of life and to extend the life expectancy of dogs diagnosed with osteosarcoma
  • To provide further evidence of the efficacy of homeopathy in serious life threatening clinical conditions where conventional therapy alone has limited success.

Recruitment strategy

The oopportunity to receive homeopathy treatment in the study. CLIENTS PLEASE CLICK HERE FOR AN APPLICATION FORM.


All dogs meeting the inclusion criteria will be accepted into the study. Recruitment will close after 30 dogs have entered the study or after 18 months, whichever is soonest.

Inclusion criteria

Dogs with diagnosis of osteosarcoma confirmed in the last three weeks by the referring vet. Diagnosis of osteosarcoma will be confirmed by a specialist vet’s report based on clinical signs and imaging. Histopathology results will be recorded but are not mandatory.

Dogs in the study will be receiving conventional treatment from the referring vet as follows:-

  1. Dogs on palliative conventional treatment only i.e painkillers such as NSAIDS and opiates.

Owner’s agreement to attend two consultations (minimum) at Wivelscombe with the dog and to provide feedback on the dog’s progress

Exclusion criteria

Concurrent disease, reported by owner or referring vet or identified during physical examination, that is likely to prevent the dog from living one year, and dogs with evidence of gross metastatic disease.

Pre-entry assessment

There will be a pre-entry assessment by the PI.

FULL PROPOSAL:  (click here)